Stockreport

Immunome Reports Second Quarter 2022 Financial Results

Immunome, Inc.  (IMNM) 
PDF EXTON, Pa.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first- [Read more]